About LabInCube
LabInCube is a company based in Cheongju-si (South Korea) founded in 2021. LabInCube has raised $13.65 million across 2 funding rounds from investors including KIPVC, Union Investment Partners and BNH INVESTMENT. LabInCube offers products and services including PlLacube Pink Ball and Industrial Filters. LabInCube operates in a competitive market with competitors including PanTher Therapeutics, PolyPid, Zyl Therapeutics, Santen Pharmaceuticals and Lexaria Bioscience, among others.
- Headquarter Cheongju-si, South Korea
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$13.65 M (USD)
in 2 rounds
-
Latest Funding Round
$9.87 M (USD), Series B
Mar 18, 2026
-
Investors
KIPVC
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of LabInCube
LabInCube offers a comprehensive portfolio of products and services, including PlLacube Pink Ball and Industrial Filters.
Enhances skin anti-aging with combined PLLA and PN components.
Captures specific gases for industrial and air purification uses.
Funding Insights of LabInCube
LabInCube has successfully raised a total of $13.65M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $9.87 million completed in March 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in LabInCube
LabInCube has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include KIPVC, Union Investment Partners and BNH INVESTMENT.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Growth stage tech and offline focused venture capital firm investing primarily in South Korea
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Early to growth stage PE and VC investments are conducted.
|
Locked | Locked | Locked |
Investor details for LabInCube
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by LabInCube
Investment portfolio details for LabInCube
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - LabInCube
Detailed financials for LabInCube
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Labincube Comparisons
Peer comparison for LabInCube
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of LabInCube
LabInCube operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as PanTher Therapeutics, PolyPid, Zyl Therapeutics, Santen Pharmaceuticals and Lexaria Bioscience, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Drug delivery systems for inoperable solid tumors are developed.
|
|
| Locked | Locked | Locked |
Technology platform enabling controlled and prolonged release of any Active Pharmaceutical Ingredient (API)
|
|
| Locked | Locked | Locked |
Hydrogel-derived nanoparticles for topical drug delivery are developed.
|
|
| Locked | Locked | Locked |
Pharmaceutical products for ophthalmology and rheumatology diseases are manufactured.
|
|
| Locked | Locked | Locked |
Patented drug delivery technology is developed for bioactive molecules.
|
Detailed competitors of LabInCube
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Labincube
Complete news archive for LabInCube
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about LabInCube
LabInCube was founded in 2021 and raised its 1st funding round 3 years after it was founded.
LabInCube is headquartered in Cheongju-si, South Korea. It is registered at Cheongju-si, North Chungcheong, South Korea.
Kyeongmin Choi is the current CEO of LabInCube.
LabInCube is a funded company, having raised a total of $13.65M across 2 funding rounds to date.
LabInCube was founded in 2021 in Cheongju-si, South Korea, focusing on the medical devices and pharmaceuticals sector. InCube technology is utilized to integrate molecular spacing and sustained release methods, reducing substance degradation while enabling controlled drug delivery over extended periods. Medical devices are created for selective drug release, supporting ongoing health management. Operations center on innovation in drug delivery systems.
LabInCube's top competitors include PanTher Therapeutics, PolyPid and Lexaria Bioscience.
LabInCube offers PlLacube Pink Ball and Industrial Filters.
LabInCube has 3 investors. Key investors include KIPVC, Union Investment Partners, and BNH INVESTMENT.